Kurt J Hilzinger - Net Worth and Insider Trading

Kurt J Hilzinger Net Worth

The estimated net worth of Kurt J Hilzinger is at least $80 Million dollars as of 2024-04-28. Kurt J Hilzinger is the President & COO of Cencora Inc and owns about 332,800 shares of Cencora Inc (COR) stock worth over $80 Million. Kurt J Hilzinger is also the Director of Outlook Therapeutics Inc and owns about 23,656 shares of Outlook Therapeutics Inc (OTLK) stock worth over $199,420. Details can be seen in Kurt J Hilzinger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kurt J Hilzinger has not made any transactions after 2022-10-05 and currently still holds the listed stock(s).

Transaction Summary of Kurt J Hilzinger

To

Kurt J Hilzinger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kurt J Hilzinger owns 3 companies in total, including Outlook Therapeutics Inc (OTLK) , Humana Inc (HUM) , and Cencora Inc (COR) .

Click here to see the complete history of Kurt J Hilzinger’s form 4 insider trades.

Insider Ownership Summary of Kurt J Hilzinger

Ticker Comapny Transaction Date Type of Owner
OTLK Outlook Therapeutics Inc 2022-10-05 director
HUM Humana Inc 2003-07-10 director
COR Cencora Inc 2007-01-29 director & President & COO

Kurt J Hilzinger Latest Holdings Summary

Kurt J Hilzinger currently owns a total of 2 stocks. Among these stocks, Kurt J Hilzinger owns 332,800 shares of Cencora Inc (COR) as of January 29, 2007, with a value of $80 Million and a weighting of 99.75%. Kurt J Hilzinger also owns 23,656 shares of Outlook Therapeutics Inc (OTLK) as of October 5, 2022, with a value of $199,420 and a weighting of 0.25%.

Latest Holdings of Kurt J Hilzinger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COR Cencora Inc 2007-01-29 332,800 240.88 80,164,864
OTLK Outlook Therapeutics Inc 2022-10-05 23,656 8.43 199,420

Holding Weightings of Kurt J Hilzinger


Kurt J Hilzinger Form 4 Trading Tracker

According to the SEC Form 4 filings, Kurt J Hilzinger has made a total of 0 transactions in Cencora Inc (COR) over the past 5 years. The most-recent trade in Cencora Inc is the sale of 240,000 shares on January 29, 2007, which brought Kurt J Hilzinger around $6 Million.

According to the SEC Form 4 filings, Kurt J Hilzinger has made a total of 5 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 5,560 shares on October 5, 2022, which cost Kurt J Hilzinger around $142,340.

Insider Trading History of Kurt J Hilzinger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kurt J Hilzinger Trading Performance

GuruFocus tracks the stock performance after each of Kurt J Hilzinger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt J Hilzinger is -23.42%. GuruFocus also compares Kurt J Hilzinger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt J Hilzinger within 3 months outperforms 5 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kurt J Hilzinger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kurt J Hilzinger

Average Return

-72.53%

Average return per transaction

Outperforming Transactions

0%

0 out of 16 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 40.24 -23.42 -46.7 -72.53 -49.04 -36.07
Relative Return to S&P 500(%) 34.93 -31.08 -57.54 -91.24 -67.47 -57.53

Kurt J Hilzinger Ownership Network

Ownership Network List of Kurt J Hilzinger

No Data

Ownership Network Relation of Kurt J Hilzinger


Kurt J Hilzinger Owned Company Details

What does Outlook Therapeutics Inc do?

Who are the key executives at Outlook Therapeutics Inc?

Kurt J Hilzinger is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .

Outlook Therapeutics Inc (OTLK) Insider Trades Summary

Over the past 18 months, Kurt J Hilzinger made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 368,671 shares made by Jeff Evanson , a net sale of 520,000 shares made by Terry Dagnon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,006 shares, with a net purchase of 5,006 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 42,552 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outlook Therapeutics Inc Insider Transactions

No Available Data

Kurt J Hilzinger Mailing Address

Above is the net worth, insider trading, and ownership report for Kurt J Hilzinger. You might contact Kurt J Hilzinger via mailing address: 1300 Morris Drive, Suite 100, Chesterbrook Pa 19087.

Discussions on Kurt J Hilzinger

No discussions yet.